A model for predicting effect of treatment on progression-free survival using MRD as a surrogate end point in CLL

Author(s):
Dimier, N.; Delmar, P.; Ward, C.; Morariu-Zamfir, R.; Fingerle-Rowson, G.; Bahlo, J.; Fischer, K.; Eichhorst, B.; Goede, V.; Dongen, J.J.M. van; Ritgen, M.; Bottcher, S.; Langerak, A.W.; Kneba, M.; Hallek, M.
Published
2018
Publication type
Article / Letter to editor
Date issued
2018-03-01
Language
English
Is part of
Blood (2018), Vol. 131, no. 9, p. 955-962
hdl
1887/96259
doi
10.1182/blood-2017-06-792333